Literature DB >> 11042436

Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients.

M Weiser1, A Reichenberg, J Rabinowitz, Z Kaplan, M Mark, D Nahon, M Davidson.   

Abstract

Despite significant research, there are still inconsistent findings regarding gender differences in cognitive performance in individuals already diagnosed with schizophrenia; studies have found that males suffering from schizophrenia are more, less or equally impaired compared with females. Gender differences in cognitive performance in individuals suffering from schizophrenia may be influenced by gender differences in premorbid cognitive performance; the very few and very small N studies published indicated that males have a poorer pre-morbid cognitive performance than females. This study examined the gender differences in premorbid cognition, utilizing cognitive assessments performed on female and male adolescents before induction into military service. The Israeli Draft Board Registry, which contains cognitive assessments equivalent to IQ scores on 16-18 year old Israeli adolescents, was linked with the Israeli National Psychiatric Hospitalization Case Registry, which records all psychiatric hospitalizations in the country. Scores on premorbid cognitive performance in schizophrenia were examined in 90 female-male case pairs matched for school attended as a proxy for socio-economic status. The mean age of first hospitalization was 20. 1+/-1.8 years of age for males and 19.6+/-1.8 years of age for females. A repeated-measures ANCOVA with age of first hospitalization and years of formal education as covariates, and controlling for gender differences in cognitive performance in healthy adolescents, revealed a significant difference in pre-morbid cognitive performance between males and females on all four cognitive measures [F(1,87)=8.07, P=0.006] with females scoring lower (worse) than males. In this national cohort, pre-morbid cognition was poorer in female, compared with male, adolescents who will suffer from schizophrenia in the future, a result consistent with some, but not all, similar studies. These results may be valid only for patients with first hospitalization around age 20. Hence, gender differences in premorbid cognition should be taken into account when assessing gender differences in cognition in schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 11042436     DOI: 10.1016/s0920-9964(99)00190-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Maria Jalbrzikowski; Roey Pasternak; Alice M Saperstein; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

2.  Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L.

Authors:  Mark Weiser; Kyra Kanyas; Dolores Malaspina; Philip D Harvey; Ittai Glick; Deborah Goetz; Osnat Karni; Avi Yakir; Neil Turetsky; Shmuel Fennig; Daniella Nahon; Bernard Lerer; Michael Davidson
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

3.  Characteristics of immigrant and non-immigrant patients in a dual-diagnosis psychiatric ward and treatment implications.

Authors:  Sophie D Walsh; David Blass; Meital Bensimon-Braverman; Lee Topaz Barak; Yael Delayahu
Journal:  J Immigr Minor Health       Date:  2014-12

4.  Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Vance M Zemon; Nadine Revheim; Alice M Saperstein; Maria Jalbrzikowski; Roey Pasternak; Gail Silipo; Daniel C Javitt
Journal:  Clin Neurophysiol       Date:  2005-09       Impact factor: 3.708

5.  Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.

Authors:  Jessie S Chambers; Nora I Perrone-Bizzozero
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

6.  Early detection of schizophrenia: current evidence and future perspectives.

Authors:  Heinz Häfner; Kurt Maurer
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

7.  Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.

Authors:  Olivia Engmann; Tibor Hortobágyi; Ruth Pidsley; Claire Troakes; Hans-Gert Bernstein; Michael R Kreutz; Jonathan Mill; Margareta Nikolic; Karl Peter Giese
Journal:  Brain       Date:  2011-07-19       Impact factor: 13.501

8.  Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients.

Authors:  Caroline C Hilti; Tarik Delko; Ariane T Orosz; Kathrin Thomann; Stephan Ludewig; Mark A Geyer; Franz X Vollenweider; Joram Feldon; Katja Cattapan-Ludewig
Journal:  Neuropsychobiology       Date:  2009-12-12       Impact factor: 2.328

9.  Neurocognition and conversion to psychosis in adolescents at high-risk.

Authors:  D J Walder; V Mittal; H D Trotman; A L McMillan; E F Walker
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

10.  Childhood cognitive function and adult psychopathology: associations with psychotic and non-psychotic symptoms in the general population.

Authors:  Jennifer H Barnett; Fiona McDougall; Man K Xu; Tim J Croudace; Marcus Richards; Peter B Jones
Journal:  Br J Psychiatry       Date:  2012-06-28       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.